Federica Marraffa
Overview
Explore the profile of Federica Marraffa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Hachem M, Diociaiuti A, Galeotti A, Grussu F, Gusson E, Ferretti A, et al.
Orphanet J Rare Dis
. 2025 Jan;
20(1):28.
PMID: 39819452
Background: Sturge-Weber Syndrome (SWS) is a rare, sporadic neurocutaneous disorder affecting the skin, brain, and eyes, due to somatic activating mutations in GNAQ or, less commonly, GNA11 gene. It is...
2.
Tolino E, Skroza N, Del Giudice E, Maddalena P, Bernardini N, Proietti I, et al.
Children (Basel)
. 2023 Jun;
10(6).
PMID: 37371163
Psoriatic disease is a chronic, relapsing inflammatory disorder, characterized mostly by cutaneous erythematous scaly plaques sometimes associated with arthritis. Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of the...
3.
Bernardini N, Skroza N, Rossi G, Mambrin A, Tolino E, Marraffa F, et al.
Dermatol Reports
. 2022 Dec;
14(4):9447.
PMID: 36483227
Psoriasis is a chronic inflammatory disease which mostly affects skin. Tildrakizumab is a specific anti-interleukin -23p19 monoclonal antibody approved for the treatment of plaque psoriasis in adults. Herein, we report...
4.
Bernardini N, Skroza N, Prevete E, Marraffa F, Proietti I, Tolino E, et al.
Dermatol Reports
. 2022 Dec;
14(4):9476.
PMID: 36483220
A wide range of comorbid conditions are associated with psoriasis, many studies have drawn attention to a higher prevalence of psychiatric comorbidities in psoriatic population. Herein, we present a case...
5.
Marraffa F, Dybala A, Grassi S, Rega F, Roberti V, Vizzaccaro A, et al.
Ital J Dermatol Venerol
. 2022 Oct;
157(5):454-455.
PMID: 36213972
No abstract available.
6.
Valentini V, Silvestri V, Bucalo A, Marraffa F, Risicato M, Grassi S, et al.
J Pers Med
. 2022 Jul;
12(7).
PMID: 35887615
Cardiovascular disease (CVD) is one of the most common comorbidities that may affect psoriatic patients. Several exogenous and endogenous factors are involved in the etiology and progression of both psoriasis...
7.
Proietti I, Bernardini N, Skroza N, Mambrin A, Tolino E, Marchesiello A, et al.
Rev Recent Clin Trials
. 2022 Jun;
PMID: 35747967
Background: Psoriasis is a chronic relapsing immune-mediated disease leading to a strong impact on patient's quality of life. The treatment of psoriasis has undergone a revolution with the advent of...
8.
Bernardini N, Skroza N, Marraffa F, Prevete E, Mambrin A, Proietti I, et al.
Dermatol Ther
. 2022 Apr;
35(7):e15533.
PMID: 35460156
No abstract available.
9.
Proietti I, Borrelli I, Skroza N, Santoro P, Gualano M, Bernardini N, et al.
Dermatol Ther
. 2022 Mar;
35(6):e15460.
PMID: 35306721
To avoid exposure to SARS-COV-2, healthcare professionals must use personal protective equipment (PPE). Their use has been related to a series of adverse effects; the most frequent adverse events were...
10.
Bernardini N, Skroza N, Marchesiello A, Mambrin A, Proietti I, Tolino E, et al.
Dermatol Ther
. 2022 Jan;
35(10):e15306.
PMID: 35100460
Psoriasis is a multifactorial, chronic, auto- inflammatory disease, with a worldwide prevalence of around 2%, subtended by robust genetic predisposition and autoimmune pathogenic traits. The disease, mainly involving the skin...